{"&cites=10318633683380081773&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy":[{"title":"Economics of health care financing","url":"https://link.springer.com/content/pdf/10.1007/978-0-230-21573-3.pdf","authors":["C Donaldson","C Donaldson K Gerard"],"year":1993,"numCitations":522,"citationUrl":"http://scholar.google.com/scholar?cites=13977414395243865146&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:OiTxQlbA-cEJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13977414395243865146&hl=en&as_sdt=2005&sciodt=0,5&scioq=pharmaceutical+policy","publication":"Springer","p":1,"exp":1596890268321},{"title":"European healthcare policies for controlling drug expenditure","url":"https://link.springer.com/article/10.2165/00019053-200321020-00002","authors":["SM Ess","SM Ess S Schneeweiss","SM Ess S Schneeweiss TD Szucs"],"year":2003,"numCitations":351,"pdf":"https://www.researchgate.net/profile/Sebastian_Schneeweiss/publication/5995256_European_Healthcare_Policies_for_Controlling_Drug_Expenditure/links/5d52233292851cd046b6ce7e/European-Healthcare-Policies-for-Controlling-Drug-Expenditure.pdf","citationUrl":"http://scholar.google.com/scholar?cites=1617658279136616817&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:cWHoV6ITcxYJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1617658279136616817&hl=en&as_sdt=2005&sciodt=0,5&scioq=pharmaceutical+policy","publication":"Springer"},{"title":"Review of the literature on reference pricing","url":"https://www.sciencedirect.com/science/article/pii/S0168851000001007","authors":["G Lopez"],"year":2000,"numCitations":279,"pdf":"https://repositori.upf.edu/bitstream/handle/10230/651/362.pdf?sequence=1&isAllowed=y","citationUrl":"http://scholar.google.com/scholar?cites=12223866794635153495&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:V9DruxXmo6kJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12223866794635153495&hl=en&as_sdt=2005&sciodt=0,5&scioq=pharmaceutical+policy","publication":"Elsevier"},{"title":"Encouraging the use of generic medicines: implications for transition economies","url":"https://www.researchgate.net/profile/Panos_Kanavos/publication/11199141_Encouraging_the_use_of_generic_medicines_Implications_for_transition_economies/links/02bfe51076f937cb44000000.pdf","authors":["DR King","DR King P Kanavos"],"year":2002,"numCitations":241,"pdf":"https://www.researchgate.net/profile/Panos_Kanavos/publication/11199141_Encouraging_the_use_of_generic_medicines_Implications_for_transition_economies/links/02bfe51076f937cb44000000.pdf","citationUrl":"http://scholar.google.com/scholar?cites=5837337509666889126&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:ph3CmYljAlEJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=5837337509666889126&hl=en&as_sdt=2005&sciodt=0,5&scioq=pharmaceutical+policy","publication":"researchgate.net"},{"title":"Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738507/","authors":["S Harbarth","S Harbarth W Albrich…"],"year":2002,"numCitations":173,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738507/","citationUrl":"http://scholar.google.com/scholar?cites=14005685296039404782&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:7iRXSpIwXsIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14005685296039404782&hl=en&as_sdt=2005&sciodt=0,5&scioq=pharmaceutical+policy","publication":"ncbi.nlm.nih.gov"},{"title":"Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies","url":"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005979/abstract","authors":["M Aaserud","M Aaserud A Austvoll‐Dahlgren…"],"year":2006,"numCitations":171,"citationUrl":"http://scholar.google.com/scholar?cites=15696858560111371310&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:LuT85LFx1tkJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15696858560111371310&hl=en&as_sdt=2005&sciodt=0,5&scioq=pharmaceutical+policy","publication":"cochranelibrary.com"},{"title":"Competition in off-patent drug markets: Issues, regulation and evidence","url":"https://academic.oup.com/economicpolicy/article-abstract/23/55/500/2918768","authors":["P Kanavos","P Kanavos J Costa"],"year":2008,"numCitations":162,"pdf":"http://www.lse.ac.uk/LSEHealthAndSocialCare/pdf/Genericmedicines/CompetitioninOff-PatentDrugMarkets.pdf","citationUrl":"http://scholar.google.com/scholar?cites=11548713844369472125&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:fTpHwg1GRaAJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11548713844369472125&hl=en&as_sdt=2005&sciodt=0,5&scioq=pharmaceutical+policy","publication":"academic.oup.com"},{"title":"A comparative analysis of generics markets in five European countries","url":"https://www.sciencedirect.com/science/article/pii/S0168851000000610","authors":["L Garattini","L Garattini F Tediosi"],"year":2000,"numCitations":155,"pdf":"https://www.academia.edu/download/48645731/s0168-8510_2800_2900061-020160907-31258-1pqjhvs.pdf","citationUrl":"http://scholar.google.com/scholar?cites=2865438290239951065&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:2RCOd_EUxCcJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2865438290239951065&hl=en&as_sdt=2005&sciodt=0,5&scioq=pharmaceutical+policy","publication":"Elsevier"},{"title":"Pharmaceutical reform and physician strikes in Korea: separation of drug prescribing and dispensing","url":"https://www.sciencedirect.com/science/article/pii/S0277953602003787","authors":["S Kwon"],"year":2003,"numCitations":139,"citationUrl":"http://scholar.google.com/scholar?cites=4266525796831663522&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:ohUxcZu-NTsJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4266525796831663522&hl=en&as_sdt=2005&sciodt=0,5&scioq=pharmaceutical+policy","publication":"Elsevier"},{"title":"Control of multiply resistant cocci: do international comparisons help?","url":"https://www.sciencedirect.com/science/article/pii/S1473309901001207","authors":["S Harbarth","S Harbarth W Albrich","S Harbarth W Albrich DA Goldmann…"],"year":2001,"numCitations":120,"pdf":"https://www.academia.edu/download/48865672/Control_of_multiply_resistant_cocci_Do_i20160915-9211-21ctde.pdf","citationUrl":"http://scholar.google.com/scholar?cites=8707321698337731106&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:IrJ4hvOe1ngJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8707321698337731106&hl=en&as_sdt=2005&sciodt=0,5&scioq=pharmaceutical+policy","publication":"Elsevier"}]}